Jeff Boyd was named vice president, chief scientific officer and director of the Cancer Institute’s Center for Genomic Medicine at The Northwell Health Cancer Institute. He will also hold an appointment as professor and member of the Cold Spring Harbor Laboratory Cancer Center.
More than a year after a catastrophic shortage of platinum-based chemotherapy drugs swept through the U.S., FDA on June 28 officially removed carboplatin and cisplatin from the drug shortage list.
